| Dr Eseroghene Otah, MD | |
|
138 Eldridge Rd, Suite E, Sugar Land, TX 77478-4083 | |
| (281) 232-3886 | |
| (281) 232-3986 |
| Full Name | Dr Eseroghene Otah |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 28 Years |
| Location | 138 Eldridge Rd, Sugar Land, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477541621 | NPI | - | NPPES |
| 1663841 | Medicaid | TX | |
| 1703076 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | L6554 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hca Houston Healthcare West | Houston, TX | Hospital |
| Entity Name | Center For General & Laparoscopic Surgery Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376531905 PECOS PAC ID: 2769443902 Enrollment ID: O20041021000554 |
News Archive
A research group in Bergen has discovered a new form of diabetes. In addition to high blood sugar levels, the disease is characterised by a decrease in pancreatic functioning and reduced fat absorption in the intestine. The discovery may have an impact on the treatment of more usual forms of diabetes.
University of Michigan researchers have solved the structure of a protein that is integral to processes responsible for maintaining a healthy heart and nervous system.
Portola Pharmaceuticals, Inc., Bristol-Myers Squibb Company and Pfizer Inc. today announced a clinical collaboration agreement to conduct a proof-of-concept study of PRT4445 and the investigational oral Factor Xa inhibitor ELIQUIS (apixaban).
Forest Laboratories, Inc. and Almirall, S.A. today announced top-line results from ACCORD COPD II, a 12-week Phase III study comparing the efficacy and safety of inhaled aclidinium bromide, an investigative bronchodilator, to placebo in 544 patients with moderate to severe COPD.
› Verified 6 days ago
| Entity Name | Round Table Specialist Group, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497152268 PECOS PAC ID: 1254754609 Enrollment ID: O20200702000716 |
News Archive
A research group in Bergen has discovered a new form of diabetes. In addition to high blood sugar levels, the disease is characterised by a decrease in pancreatic functioning and reduced fat absorption in the intestine. The discovery may have an impact on the treatment of more usual forms of diabetes.
University of Michigan researchers have solved the structure of a protein that is integral to processes responsible for maintaining a healthy heart and nervous system.
Portola Pharmaceuticals, Inc., Bristol-Myers Squibb Company and Pfizer Inc. today announced a clinical collaboration agreement to conduct a proof-of-concept study of PRT4445 and the investigational oral Factor Xa inhibitor ELIQUIS (apixaban).
Forest Laboratories, Inc. and Almirall, S.A. today announced top-line results from ACCORD COPD II, a 12-week Phase III study comparing the efficacy and safety of inhaled aclidinium bromide, an investigative bronchodilator, to placebo in 544 patients with moderate to severe COPD.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eseroghene Otah, MD 138 Eldridge Rd, Suite E, Sugar Land, TX 77478-4083 Ph: (281) 232-3886 | Dr Eseroghene Otah, MD 138 Eldridge Rd, Suite E, Sugar Land, TX 77478-4083 Ph: (281) 232-3886 |
News Archive
A research group in Bergen has discovered a new form of diabetes. In addition to high blood sugar levels, the disease is characterised by a decrease in pancreatic functioning and reduced fat absorption in the intestine. The discovery may have an impact on the treatment of more usual forms of diabetes.
University of Michigan researchers have solved the structure of a protein that is integral to processes responsible for maintaining a healthy heart and nervous system.
Portola Pharmaceuticals, Inc., Bristol-Myers Squibb Company and Pfizer Inc. today announced a clinical collaboration agreement to conduct a proof-of-concept study of PRT4445 and the investigational oral Factor Xa inhibitor ELIQUIS (apixaban).
Forest Laboratories, Inc. and Almirall, S.A. today announced top-line results from ACCORD COPD II, a 12-week Phase III study comparing the efficacy and safety of inhaled aclidinium bromide, an investigative bronchodilator, to placebo in 544 patients with moderate to severe COPD.
› Verified 6 days ago
Dr. Michelle O'shea, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 16655 Southwest Freeway, Ste 561, Sugar Land, TX 77479 Phone: 281-494-3000 Fax: 281-494-3010 | |
Dr. Robert Morgan Hillery, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 17510 W Grand Pkwy S, Suite 490, Sugar Land, TX 77479 Phone: 713-772-1200 Fax: 281-342-3957 | |
Ulises Baltazar, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 16605 Southwest Fwy, Suite 505, Sugar Land, TX 77479 Phone: 281-240-8400 Fax: 281-240-8405 | |
Mr. Khaja Moinuddeen, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 4911 Sandhill Dr, Sugar Land, TX 77479 Phone: 281-238-7870 Fax: 281-633-4985 | |
Michelle Chout-win Shen, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 17510 W Grand Pkwy S Ste 190, Sugar Land, TX 77479 Phone: 713-486-1330 | |
Dr. Eric Allen Humble, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 16525 Lexington Blvd, Suite 150, Sugar Land, TX 77479 Phone: 281-313-0555 Fax: 281-313-0554 | |
Dr. Aman Barkat Ali, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 16651 Southwest Fwy Ste 450, Sugar Land, TX 77479 Phone: 281-275-0212 Fax: 281-275-0291 |